Takeda Pharmaceutical Company Limited (4502.T)
JPY 4448.0
(-0.04%)
JPY 4448.0
(-0.04%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 15108.79 Billion JPY | 8.25% |
| 2022 | 13957.75 Billion JPY | 5.92% |
| 2021 | 13178.01 Billion JPY | 2.06% |
| 2020 | 12912.29 Billion JPY | 0.71% |
| 2019 | 12821.09 Billion JPY | -7.58% |
| 2018 | 13872.32 Billion JPY | 237.82% |
| 2017 | 4106.46 Billion JPY | -5.72% |
| 2016 | 4355.78 Billion JPY | 13.9% |
| 2015 | 3824.08 Billion JPY | -10.99% |
| 2014 | 4296.19 Billion JPY | -5.97% |
| 2013 | 4569.14 Billion JPY | 15.51% |
| 2012 | 3955.59 Billion JPY | 10.58% |
| 2011 | 3577.03 Billion JPY | 28.37% |
| 2010 | 2786.4 Billion JPY | -1.31% |
| 2009 | 2823.27 Billion JPY | 2.29% |
| 2008 | 2760.18 Billion JPY | -3.13% |
| 2007 | 2849.27 Billion JPY | -7.27% |
| 2006 | 3072.5 Billion JPY | 0.99% |
| 2005 | 3042.29 Billion JPY | 19.52% |
| 2004 | 2545.43 Billion JPY | 8.98% |
| 2003 | 2335.66 Billion JPY | 13.42% |
| 2002 | 2059.36 Billion JPY | 4.79% |
| 2001 | 1965.21 Billion JPY | 12.44% |
| 2000 | 1747.77 Billion JPY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 16227.68 Billion JPY | 7.41% |
| 2024 Q2 | 14573 Billion JPY | -10.2% |
| 2023 Q1 | 14792.73 Billion JPY | 5.98% |
| 2023 Q4 | 15108.79 Billion JPY | 6.23% |
| 2023 Q2 | 14871.88 Billion JPY | 0.54% |
| 2023 Q3 | 14222.94 Billion JPY | -4.36% |
| 2023 FY | 15108.79 Billion JPY | 8.25% |
| 2022 Q1 | 14065.42 Billion JPY | 6.73% |
| 2022 Q4 | 13957.75 Billion JPY | 3.35% |
| 2022 Q3 | 13504.7 Billion JPY | -7.43% |
| 2022 Q2 | 14588.84 Billion JPY | 3.72% |
| 2022 FY | 13957.75 Billion JPY | 5.92% |
| 2021 Q4 | 13178.01 Billion JPY | 3.78% |
| 2021 Q2 | 12560.27 Billion JPY | -0.77% |
| 2021 Q1 | 12657.23 Billion JPY | -1.98% |
| 2021 FY | 13178.01 Billion JPY | 2.06% |
| 2021 Q3 | 12698.51 Billion JPY | 1.1% |
| 2020 FY | 12912.29 Billion JPY | 0.71% |
| 2020 Q1 | 12613.85 Billion JPY | -1.62% |
| 2020 Q2 | 12414.74 Billion JPY | -1.58% |
| 2020 Q3 | 12286.13 Billion JPY | -1.04% |
| 2020 Q4 | 12912.29 Billion JPY | 5.1% |
| 2019 FY | 12821.09 Billion JPY | -7.58% |
| 2019 Q3 | 13031.49 Billion JPY | 1.18% |
| 2019 Q2 | 12880.14 Billion JPY | -4.95% |
| 2019 Q1 | 13550.42 Billion JPY | -2.32% |
| 2019 Q4 | 12821.09 Billion JPY | -1.61% |
| 2018 Q4 | 13872.32 Billion JPY | 140.54% |
| 2018 Q3 | 5767.22 Billion JPY | 34.91% |
| 2018 Q2 | 4274.83 Billion JPY | 2.77% |
| 2018 Q1 | 4159.57 Billion JPY | 1.29% |
| 2018 FY | 13872.32 Billion JPY | 237.82% |
| 2017 Q1 | 4345.92 Billion JPY | -0.23% |
| 2017 FY | 4106.46 Billion JPY | -5.72% |
| 2017 Q4 | 4106.46 Billion JPY | -6.89% |
| 2017 Q3 | 4410.55 Billion JPY | 0.79% |
| 2017 Q2 | 4375.95 Billion JPY | 0.69% |
| 2016 Q2 | 3801.81 Billion JPY | -0.4% |
| 2016 Q4 | 4355.78 Billion JPY | 5.16% |
| 2016 Q3 | 4142.03 Billion JPY | 8.95% |
| 2016 Q1 | 3817.01 Billion JPY | -0.18% |
| 2016 FY | 4355.78 Billion JPY | 13.9% |
| 2015 FY | 3824.08 Billion JPY | -10.99% |
| 2015 Q4 | 3824.08 Billion JPY | -8.73% |
| 2015 Q3 | 4189.87 Billion JPY | -0.57% |
| 2015 Q2 | 4213.82 Billion JPY | -2.48% |
| 2015 Q1 | 4320.85 Billion JPY | 0.57% |
| 2014 Q3 | 4653.37 Billion JPY | 1.78% |
| 2014 FY | 4296.19 Billion JPY | -5.97% |
| 2014 Q1 | 4437.32 Billion JPY | -2.88% |
| 2014 Q2 | 4571.8 Billion JPY | 3.03% |
| 2014 Q4 | 4296.19 Billion JPY | -7.68% |
| 2013 Q4 | 4569.14 Billion JPY | 3.24% |
| 2013 FY | 4569.14 Billion JPY | 15.51% |
| 2013 Q3 | 4425.78 Billion JPY | 4.06% |
| 2013 Q2 | 4253.21 Billion JPY | 8.12% |
| 2013 Q1 | 3933.71 Billion JPY | -0.55% |
| 2012 FY | 3955.59 Billion JPY | 10.58% |
| 2012 Q1 | 3467.95 Billion JPY | -3.05% |
| 2012 Q4 | 3955.59 Billion JPY | 4.54% |
| 2012 Q2 | 3482.16 Billion JPY | 0.41% |
| 2012 Q3 | 3783.72 Billion JPY | 8.66% |
| 2011 Q2 | 3499.28 Billion JPY | 28.96% |
| 2011 FY | 3577.03 Billion JPY | 28.37% |
| 2011 Q3 | 3421.38 Billion JPY | -2.23% |
| 2011 Q1 | 2713.56 Billion JPY | -2.61% |
| 2011 Q4 | 3577.03 Billion JPY | 4.55% |
| 2010 Q4 | 2786.4 Billion JPY | 3.97% |
| 2010 Q1 | 2684.34 Billion JPY | -4.92% |
| 2010 Q2 | 2708.66 Billion JPY | 0.91% |
| 2010 Q3 | 2680.06 Billion JPY | -1.06% |
| 2010 FY | 2786.4 Billion JPY | -1.31% |
| 2009 Q2 | 2739.93 Billion JPY | 0.0% |
| 2009 FY | 2823.27 Billion JPY | 2.29% |
| 2009 Q4 | 2823.27 Billion JPY | 2.54% |
| 2009 Q3 | 2753.31 Billion JPY | 0.49% |
| 2008 FY | 2760.18 Billion JPY | -3.13% |
| 2008 Q3 | 2554.65 Billion JPY | 0.0% |
| 2008 Q4 | 2760.18 Billion JPY | 8.05% |
| 2007 FY | 2849.27 Billion JPY | -7.27% |
| 2006 FY | 3072.5 Billion JPY | 0.99% |
| 2005 FY | 3042.29 Billion JPY | 19.52% |
| 2004 FY | 2545.43 Billion JPY | 8.98% |
| 2003 FY | 2335.66 Billion JPY | 13.42% |
| 2002 FY | 2059.36 Billion JPY | 4.79% |
| 2001 FY | 1965.21 Billion JPY | 12.44% |
| 2000 FY | 1747.77 Billion JPY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 36.57 Billion JPY | -41211.328% |
| Sumitomo Pharma Co., Ltd. | 907.5 Billion JPY | -1564.87% |
| Shionogi & Co., Ltd. | 1416.91 Billion JPY | -966.314% |
| Wakamoto Pharmaceutical Co.,Ltd. | 15.42 Billion JPY | -97875.093% |
| Nippon Shinyaku Co., Ltd. | 263.4 Billion JPY | -5635.977% |
| Kaken Pharmaceutical Co., Ltd. | 171.62 Billion JPY | -8703.477% |
| Eisai Co., Ltd. | 1393.79 Billion JPY | -984.001% |
| Morishita Jintan Co., Ltd. | 17.18 Billion JPY | -87828.72% |
| Hisamitsu Pharmaceutical Co., Inc. | 328.77 Billion JPY | -4495.425% |
| Mochida Pharmaceutical Co., Ltd. | 158.8 Billion JPY | -9414.353% |
| Fuso Pharmaceutical Industries,Ltd. | 76.46 Billion JPY | -19660.387% |
| Nippon Chemiphar Co., Ltd. | 49.54 Billion JPY | -30393.243% |
| Tsumura & Co. | 428.25 Billion JPY | -3427.998% |
| Kissei Pharmaceutical Co., Ltd. | 260.92 Billion JPY | -5690.384% |
| Torii Pharmaceutical Co., Ltd. | 133.43 Billion JPY | -11223.215% |
| Towa Pharmaceutical Co., Ltd. | 430.65 Billion JPY | -3408.345% |
| Fuji Pharma Co., Ltd. | 85.33 Billion JPY | -17605.892% |
| Zeria Pharmaceutical Co., Ltd. | 150.53 Billion JPY | -9936.824% |
| KYORIN Holdings, Inc. | 177.67 Billion JPY | -8403.42% |
| Taiko Pharmaceutical Co.,Ltd. | 15.04 Billion JPY | -100317.334% |
| Daito Pharmaceutical Co.,Ltd. | 77.7 Billion JPY | -19343.033% |
| SymBio Pharmaceuticals Limited | 15.35 Billion JPY | -98315.507% |
| MedRx Co., Ltd | 2.05 Billion JPY | -736195.906% |
| Mizuho Medy Co.,Ltd. | 18.94 Billion JPY | -79636.817% |
| Solasia Pharma K.K. | 2.55 Billion JPY | -592401.647% |
| Modalis Therapeutics Corporation | 2.02 Billion JPY | -745672.524% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 93.31 Billion JPY | -16091.692% |
| Sawai Group Holdings Co., Ltd. | 382.02 Billion JPY | -3854.933% |
| Cyfuse Biomedical K.K. | 4.21 Billion JPY | -358369.198% |
| Toho Holdings Co., Ltd. | 773.42 Billion JPY | -1853.486% |
| Koa Shoji Holdings Co.,Ltd. | 32 Billion JPY | -47109.05% |